Literature DB >> 1580592

Chlamydia pneumoniae, strain TWAR pneumonia.

J T Grayston1.   

Abstract

Chlamydia pneumoniae, strain TWAR is a newly recognized third species of Chlamydia. It is an important cause of pneumonia, bronchitis, sinusitis, and other acute respiratory infections. It is a human pathogen transmitted by the respiratory route. Successful antibiotic treatment with tetracycline or erythromycin requires high dosage and a prolonged course.

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1580592     DOI： 10.1146/annurev.me.43.020192.001533

Source DB:  PubMed          Journal:  Annu Rev Med        ISSN： 0066-4219            Impact factor:   13.739


  29 in total

1.  Inhibition of Chlamydia pneumoniae replication in human aortic smooth muscle cells by gamma interferon-induced indoleamine 2, 3-dioxygenase activity.

Authors:  L G Pantoja; R D Miller; J A Ramirez; R E Molestina; J T Summersgill
Journal:  Infect Immun       Date:  2000-11       Impact factor: 3.441

2.  Practice guidelines for the management of community-acquired pneumonia in adults. Infectious Diseases Society of America.

Authors:  J G Bartlett; S F Dowell; L A Mandell; T M File; D M Musher; M J Fine
Journal:  Clin Infect Dis       Date:  2000-09-07       Impact factor: 9.079

Review 3.  Formulary management of macrolide antibiotics.

Authors:  D R Guay
Journal:  Pharmacoeconomics       Date:  1995-12       Impact factor: 4.981

4.  Localization of the hypothetical protein Cpn0797 in the cytoplasm of Chlamydia pneumoniae-infected host cells.

Authors:  Feng Dong; Rhonda Flores; Ding Chen; Jianhua Luo; Youmin Zhong; Zhongming Wu; Guangming Zhong
Journal:  Infect Immun       Date:  2006-11       Impact factor: 3.441

5.  Hypothetical protein Cpn0308 is localized in the Chlamydia pneumoniae inclusion membrane.

Authors:  Jianhua Luo; Tianjun Jia; Rhonda Flores; Ding Chen; Guangming Zhong
Journal:  Infect Immun       Date:  2006-11-13       Impact factor: 3.441

6.  Rifalazil pretreatment of mammalian cell cultures prevents subsequent Chlamydia infection.

Authors:  Robert J Suchland; Kara Brown; David M Rothstein; Walter E Stamm
Journal:  Antimicrob Agents Chemother       Date:  2006-02       Impact factor: 5.191

7.  Synergistic Costimulatory Effect of Chlamydia pneumoniae with Carbon Nanoparticles on NLRP3 Inflammasome-Mediated Interleukin-1β Secretion in Macrophages.

Authors:  Junji Matsuo; Shinji Nakamura; Seiji Takeda; Kasumi Ishida; Tomohiro Yamazaki; Mitsutaka Yoshida; Hitoshi Chiba; Shu-Ping Hui; Hiroyuki Yamaguchi
Journal:  Infect Immun       Date:  2015-05-04       Impact factor: 3.441

8.  Genome sequence of Chlamydophila caviae (Chlamydia psittaci GPIC): examining the role of niche-specific genes in the evolution of the Chlamydiaceae.

Authors:  T D Read; G S A Myers; R C Brunham; W C Nelson; I T Paulsen; J Heidelberg; E Holtzapple; H Khouri; N B Federova; H A Carty; L A Umayam; D H Haft; J Peterson; M J Beanan; O White; S L Salzberg; R-c Hsia; G McClarty; R G Rank; P M Bavoil; C M Fraser
Journal:  Nucleic Acids Res       Date:  2003-04-15       Impact factor: 16.971

9.  In vitro activities of azithromycin and doxycycline against 15 isolates of Chlamydia pneumoniae.

Authors:  J Gnarpe; K Eriksson; H Gnarpe
Journal:  Antimicrob Agents Chemother       Date:  1996-08       Impact factor: 5.191

10.  Initial characterization of Chlamydophila (Chlamydia) pneumoniae cultured from the late-onset Alzheimer brain.

Authors:  Ute Dreses-Werringloer; Mohammad Bhuiyan; Yinghao Zhao; Hervé C Gérard; Judith A Whittum-Hudson; Alan P Hudson
Journal:  Int J Med Microbiol       Date:  2008-09-30       Impact factor: 3.473
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.